A cohort study to study fever in the community with focus on Dengue and Chikungunya in India
Not Applicable
- Conditions
- Health Condition 1: A920- Chikungunya virus diseaseHealth Condition 2: A90- Dengue fever [classical dengue]
- Registration Number
- CTRI/2023/05/053013
- Lead Sponsor
- Dr Winsley Rose
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Individuals currently residing and likely to stay till the end of one year in the study area
2 Consented to participate in both sections of the study (Sero Prevalence and AFI Surveillance) and follow all procedures.
Exclusion Criteria
Ongoing fever episodes or history of AFI on or before enrolment for the cohort
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1 Age specific attack rate <br/ ><br>2 Age-specific cumulative incidence of asymptomatic infections <br/ ><br>3 Age-specific cumulative incidence of symptomatic events <br/ ><br>4. Age Specific sero prevalence and seroincidence of neutralizing antibodies <br/ ><br>5. Symptomatic proportion of cases (asymptomatic fraction) <br/ ><br>6. Prevalence and incidence of Circulating serotypes <br/ ><br>7. Population groups most at risk <br/ ><br>8. Validity of IgG ELISA <br/ ><br>9. Economic burden of Dengue and Chikungunya <br/ ><br>Timepoint: The AFI study will be conducted for a period of 12 months with serosurvey for dengue and chikungunya at baseline and endline
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil